SERB SA
7Patents
7Active
7Granted
56Portfolio score
Filing activity: Jun 29, 2012 → May 23, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10793893B2 | Methods of administering 3,4-diaminopyridine | Emerging Cross-Sectional Technologies | 6 | Active |
| US11060128B2 | Methods of administering 3,4-diaminopyridine | Emerging Cross-Sectional Technologies | 5 | Active |
| US11274331B2 | Methods of administering 3,4-diaminopyridine | Emerging Cross-Sectional Technologies | 2 | Active |
| US11268128B2 | Methods of administering 3,4-diaminopyridine | Emerging Cross-Sectional Technologies | 2 | Active |
| US11274332B2 | Methods of administering 3,4-diaminopyridine | Emerging Cross-Sectional Technologies | 2 | Active |
| US11873525B2 | Methods of administering 3,4-diaminopridine | Emerging Cross-Sectional Technologies | 0 | Active |
| US11845977B2 | Methods of administering 3,4-diaminopridine | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.